Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial
Thomas G Evans, Louise Bussey, Elizabeth Eagling-Vose, Kathryn Rutkowski, Chris Ellis, Chris Argent, Paul Griffin, Joshua Kim, Susan Thackwray, Sepehr Shakib, Julia Doughty, John Gillies, Jian Wu, Julian Druce, Melinda Pryor, Sarah Gilbert
Topics & Concepts
MedicineSeasonal influenzaVirologyInfluenza vaccineVaccinationLive attenuated influenza vaccineImmunologyClinical trialSeroconversionTrivalent influenza vaccineVaccine efficacyInternal medicinePhase (matter)ImmunizationImmunogenicityAntibody responsePediatricsIncidence (geometry)Vaccine trialInfluenza Virus Research StudiesImmune responses and vaccinationsT-cell and B-cell Immunology